Company / Operating Income
Adaptive Biotechnologies Corp Operating Income History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$57.1M
FY2025
5-year range
-$227.0M / -$57.1M
FY2021-FY2025
Trend
+64.9%
vs FY2024
Sector context
#75 of 204
Health Care
What the data says
At -$57M, Adaptive Biotechnologies Corp's operating income ranks #75 of 204 in the Health Care sector. Operating Income has fluctuated over the past 9 years, ranging from -$227M in FY2023 to -$44M in FY2017.
Based on SEC 10-K filings.
-$57M in FY2025.
Improved from -$227M to -$57M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#75 of 204 in Health CareTop 37% of 204This company -$57.1M Sector average $107.8M
▼
-153.0% below sector average
Key checks
Key Insights
- In FY2025, operating income increased 64.9% year-over-year.
- Ranks #75 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2017.
- Lowest operating income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.45 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$57.1M | +64.9% |
| FY2024 | -$162.5M | +28.4% |
| FY2023 | -$227.0M | -13.4% |
| FY2022 | -$200.2M | +4.2% |
| FY2021 | -$209.0M | -36.7% |
| FY2020 | -$152.8M | -94.9% |
| FY2019 | -$78.4M | -57.6% |
| FY2018 | -$49.8M | -11.9% |
| FY2017 | -$44.5M | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026